New Product Development
Revising its market forecast to negative 2.1% (volume) for 2022, the ESOMAR-certified market research and consulting firm remains bullish on the long-term prospects of the market. FMI has forecast the global polypropylene sales to reach a valuation of US$ 117,513.8 Mn in 2030. The COVID-19 induced subdued momentum, especially in construction and automotive sectors, is likely to …
Continue reading “Polypropylene Market Sales to Reach a Valuation of US$ 117,513.8 Million in 2030”
The global Dengue Fever Treatment Market is expected to generate a market value of US$ 877.82 Million in 2023 and a market value of US$ 5435.25 Million by 2033, with a CAGR of 20% from 2023 to 2033. From 2018 to 2022, the market for Dengue Fever Treatment grew at an 11% CAGR. According to …
Continue reading “Dengue Fever Treatment Market is expected to reach US$ 5435.25 Million by 2033”
According to a recent report published by Future Market Insights, the global bartonellosis therapeutics market is slated to grow at a CAGR of 12% from 2023 to 2033, reaching a market value of US$ 3.72 Billion by the end of the said period of assessment. A robust product pipeline, in addition to upcoming launches, propelling …
Continue reading “Bartonellosis Therapeutics Market is expected to grow at a CAGR of 12% by 2033”
The global alcohol use disorder treatment market was worth US$ 700 million in 2023 and is expected to be worth US$ 1,300 million by 2033, growing at a CAGR of 6.4% between 2023 and 2033. The increased prevalence of alcohol abuse and binge drinking is expected to fuel the industry. This disease knows no bounds …
According to Future Market Insights, the global pork tapeworm infection treatment is expected to grow at a CAGR of 8% between 2023 and 2033, reaching US$ 25.17 Billion in 2033. It is expected that the market will further grow as the number of test kits and devices continues to increase. It is expected that the …
Continue reading “Pork Tapeworm Infection Treatment Market to expand at a CAGR of 8% by 2033”
A recently published study by FMI expects the global Laband syndrome therapeutics market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 5 Billion is expected for the market. Rising awareness of rare diseases and increased attention to heredity-related problems in the …
According to a recently published study by Future Market Insights, the global hyperammonemia treatment market size is expected to reach a valuation of US$ 1,318.05 Million in 2023 and is projected to reach US$ 2,100 Million by 2033, trailing a CAGR of 4.77%. The rising prevalence of urea cycle disorders and extensive research and development …
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in …
The global restrictive cardiomyopathy treatment market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Restrictive Cardiomyopathy Treatment registered a CAGR of 4% …
According to a recent report published by Future Market Insights (FMI), the global Direct reduced iron market is projected to reach revenues worth US$ 16,789.0 Mn by 2030 end, with growth projected at an impressive CAGR between 2022 and 2030. Direct reduced iron (DRI) has recently emerged as a quality supplement, in place of scrap steel, among …
